Institutional
Commodore Capital LP
CIK 0001831942
$1.73B
Reported AUM
36
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Commodore Capital LP · Q1 2026
AI · grounded in 13F
Commodore Capital LP exited its position in Terns Pharmaceuticals Inc 430, reducing exposure by $59.6M. The fund established new positions in Erasca Inc ERAS and Damora Therapeutics Inc DMRA, adding $51.4M and $50.2M respectively. Other notable activity includes new stakes in Definium Therapeutics Inc DFTX and Eyepoint Inc EYPT, alongside a full exit from Oruka Therapeutics Inc.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RLAY | RELAY THERAPEUTICS INC | $13.52 | -7.02% | 302.38% | -58.32% | $169.2M | 9.79% | — | HELD |
| 2 | ALKS | ALKERMES PLC | $42.80 | -1.34% | 34.97% | 65.44% | $148.5M | 8.59% | +650,000 | +18.3% |
| 3 | ELVN | ENLIVEN THERAPEUTICS INC | $34.71 | -2.20% | 67.36% | 60.99% | $128.4M | 7.43% | −1,417,809 | −30.2% |
| 4 | COGT | COGENT BIOSCIENCES INC | $31.02 | -5.40% | 356.18% | 417.00% | $111.2M | 6.43% | +691,162 | +31.5% |
| 5 | SYRE | SPYRE THERAPEUTICS INC | $73.65 | -6.15% | 334.00% | -51.94% | $96.5M | 5.58% | −475,865 | −19.9% |
| 6 | TYRA | TYRA BIOSCIENCES INC | $26.64 | -1.99% | 152.51% | 18.98% | $94.8M | 5.48% | −900,000 | −26.7% |
| 7 | CLDX | CELLDEX THERAPEUTICS INC NEW | $28.62 | -4.38% | 34.05% | -34.58% | $85.5M | 4.95% | +131,616 | +5.1% |
| 8 | NUVL | NUVALENT INC | $90.95 | -3.27% | 16.57% | 149.66% | $85.4M | 4.94% | +283,600 | +51.6% |
| 9 | AMLX | AMYLYX PHARMACEUTICALS INC | $13.32 | -6.92% | 149.91% | -59.51% | $78.5M | 4.54% | — | HELD |
| 10 | KYMR | KYMERA THERAPEUTICS INC | $74.13 | -0.64% | 55.67% | 23.18% | $62.5M | 3.61% | — | HELD |
| 11 | ANRO | ALTO NEUROSCIENCE INC | $18.26 | -8.84% | 610.51% | 18.96% | $61.2M | 3.54% | +900,000 | +49.4% |
| 12 | PHVS | PHARVARIS N V | $31.09 | -1.71% | 85.28% | 74.96% | $54.2M | 3.14% | +29,525 | +1.6% |
| 13 | ERAS | ERASCA INC | $11.97 | -9.80% | 648.13% | -49.94% | $51.4M | 2.97% | +3,175,000 | NEW |
| 14 | DMRA | DAMORA THERAPEUTICS INC | $21.01 | -5.83% | 538.60% | -80.41% | $50.2M | 2.91% | +1,939,000 | NEW |
| 15 | XENE | XENON PHARMACEUTICALS INC | $51.73 | -2.38% | 63.50% | 199.54% | $48.0M | 2.78% | −975,000 | −54.2% |
| 16 | DFTX | DEFINIUM THERAPEUTICS INC | $23.55 | -4.23% | 202.31% | -48.69% | $37.8M | 2.19% | +2,000,000 | NEW |
| 17 | LBRX | LB PHARMACEUTICALS INC | $28.53 | -1.28% | 69.82% | 76.88% | $37.0M | 2.14% | — | HELD |
| 18 | EYPT | EYEPOINT INC | $11.78 | -3.92% | 31.77% | 43.31% | $36.4M | 2.11% | +2,825,000 | NEW |
| 19 | NRIX | NURIX THERAPEUTICS INC | $14.64 | -4.19% | 14.55% | -52.37% | $35.3M | 2.04% | — | HELD |
| 20 | CRVS | CORVUS PHARMACEUTICALS INC | $11.12 | -5.12% | 184.40% | 432.06% | $33.0M | 1.91% | +2,258,735 | NEW |
| 21 | ASMB | ASSEMBLY BIOSCIENCES INC | $22.90 | -5.02% | 41.01% | -45.00% | $27.8M | 1.61% | — | HELD |
| 22 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.03 | -6.77% | -8.73% | -56.09% | $26.4M | 1.53% | +6,336,782 | NEW |
| 23 | SLNO | SOLENO THERAPEUTICS INC | $53.01 | 0.00% | -29.80% | 288.35% | $21.8M | 1.26% | −547,568 | −45.6% |
| 24 | OCUL | OCULAR THERAPEUTIX INC | $8.25 | -6.25% | -8.54% | -25.07% | $21.8M | 1.26% | +2,575,000 | NEW |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $2.13 | -3.18% | 245.78% | -92.69% | $19.7M | 1.14% | +8,695,652 | NEW |
| 26 | ZURA | ZURA BIO LTD | $3.40 | -7.36% | 169.84% | -50.07% | $19.3M | 1.12% | +3,250,000 | NEW |
| 27 | SABS | SAB BIOTHERAPEUTICS INC | $3.38 | -2.59% | 86.74% | -96.59% | $16.9M | 0.98% | — | HELD |
| 28 | PALI | PALISADE BIO INC | $1.74 | -9.84% | 148.57% | -99.92% | $12.6M | 0.73% | −4,263,938 | −37.3% |
| 29 | KPTI | KARYOPHARM THERAPEUTICS INC | $9.08 | 0.11% | 102.23% | -92.73% | $10.9M | 0.63% | +1,950,000 | NEW |
| 30 | IKT | INHIBIKASE THERAPEUTICS INC | $1.63 | -1.81% | -16.84% | -88.03% | $9.1M | 0.52% | — | HELD |
| 31 | ANTX | AN2 THERAPEUTICS INC | $3.82 | -8.39% | — | — | $8.0M | 0.46% | +2,333,713 | NEW |
| 32 | PEPG | PEPGEN INC | $1.41 | -4.73% | — | — | $7.9M | 0.46% | +1,075,000 | +31.6% |
| 33 | AVTX | AVALO THERAPEUTICS INC | $13.10 | -3.75% | — | — | $7.2M | 0.42% | — | HELD |
| 34 | HLXC | HELIX ACQUISITION CORP III | $10.24 | -0.10% | — | — | $5.1M | 0.29% | +500,000 | NEW |
| 35 | LONA | LEONABIO INC | $8.22 | -4.53% | — | — | $4.8M | 0.28% | — | HELD |
| 36 | RLMD | RELMADA THERAPEUTICS INC | $5.95 | -5.71% | — | — | $4.4M | 0.26% | +633,901 | NEW |
| 37 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | — | — | −1,475,000 | EXITED |
| 38 | ORKA | ORUKA THERAPEUTICS INC | $60.14 | -3.44% | — | — | — | — | −1,753,054 | EXITED |
| 39 | PTGX | PROTAGONIST THERAPEUTICS INC | $97.38 | -5.26% | — | — | — | — | −450,000 | EXITED |
| 40 | CTMX | CYTOMX THERAPEUTICS INC | $3.00 | -5.66% | — | — | — | — | −7,692,300 | EXITED |
| 41 | BRD1EUR | MIND MEDICINE MINDMED INC | — | — | — | — | — | — | −2,000,000 | EXITED |
| 42 | CNTA | CENTESSA PHARMACEUTICALS PLC | $39.62 | -0.45% | — | — | — | — | −1,000,000 | EXITED |
| 43 | REPL | REPLIMUNE GROUP INC | $9.47 | -4.05% | — | — | — | — | −1,425,000 | EXITED |
| 44 | CTNM | CONTINEUM THERAPEUTICS INC | $11.49 | -6.89% | — | — | — | — | −816,326 | EXITED |
| 45 | RAPT | RAPT THERAPEUTICS INC | — | — | — | — | — | — | −250,000 | EXITED |
| 46 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $69.00 | -7.38% | — | — | — | — | −18,851 | EXITED |
Source: SEC EDGAR · accession 0001831942-26-000025. 13F discloses long positions only — shorts, foreign equities, and options are excluded.